Protein structure interpretation

Secondary Structure Analysis for Protein Modeling & Design

Helices, strands, loops, and uncertain regions are easy to annotate. The harder question is what those patterns mean for your model, variant, or experiment. CD ComputaBio combines secondary structure with model confidence, available structural evidence, and the biological question to help you choose a defensible next step.

Model assessmentVariant comparisonFlexible regionsNext-step planning
From protein sequence to an evidence-based decisionA protein sequence aligns with helical, strand, loop, and low-confidence regions, which are reviewed with structure evidence before recommending an experiment.SEQUENCE → STRUCTURE → DECISIONResidue positionStructure mapHELIXSTRANDUNCERTAIN LOOPWhich region is ready for the next step?Compare confidence, context, and experimental evidence.
Where the demand is

Turn a Structure Map into a Project Decision

Routine secondary structure assignment is widely accessible. Clients come to us when a structural observation needs to be reconciled with a model, variant, or experiment. We scope the work around one of these questions.

Model assessment

Can we trust this region?

Map helices, strands, loops, gaps, and confidence onto a target model. Compare predicted and experimental structures when available; distinguish local structural confidence from uncertainty in domain placement or alternate conformations.

Decision: use the current model, refine a defined region, or acquire stronger evidence before docking or design.

Variant comparison

Which changes deserve testing?

Locate mutations relative to secondary structure, conserved positions, local packing, contacts, and any available activity or stability data. Compare wild-type and variant models without assuming that a local prediction proves a stability change.

Decision: nominate a focused variant set and an appropriate assay readout.

Flexible regions

What does a low-confidence loop mean?

Review disorder predictions, model confidence, neighboring domains, and relevant binding context. A flexible or conditionally structured segment may need a different approach than a well-folded domain.

Decision: prioritize construct design, partner-aware modeling, further sampling, or targeted experiments.

Also relevant to peptide and antibody projects: helix formation, loop presentation, and local structural context can inform design, but a sequence-level assignment alone cannot establish affinity, developability, or biological activity. These questions are scoped under the corresponding peptide or antibody workflow.
Project fit

Can We Support Your Structure Question?

Bring the data you already have. We define the analysis depth from the biological decision, input quality, and evidence gaps.

Your situationYou provideWhat CD ComputaBio can doWhat you receive
A predicted model is availableProtein sequence, model coordinates or accession, and the region or use case of interest.Annotate structure; inspect local confidence, missing segments, structural context, and relevant reference structures.A residue-mapped assessment and recommendation for downstream modeling, docking, or validation.
Variants must be comparedWild-type sequence or structure, mutation list, and any activity, expression, or thermal data.Compare local structural context and cross-check model differences against known biological evidence.A qualified variant comparison, uncertainty flags, and suggested experimental priorities.
Flexible or disordered region mattersSequence or model, domain boundaries, partner or construct context, and project question.Assess confidence, predicted disorder, alternative context, and whether ensemble or partner-aware modeling is appropriate.A focused follow-up plan rather than a single asserted structure for a flexible segment.
Only a sequence is availableSequence, organism, intended application, and any known homolog or assay evidence.Review suitable public models and determine whether a structural workflow is justified.A feasibility assessment and defined path to a useful structural decision.

RNA secondary structure calls for a separate workflow with different inputs, constraints, and validation; mention your RNA question in the inquiry form and we can scope it separately.

Project outputs

See What a Structure Assessment Delivers

The example below shows the format of a decision-oriented output. It is a schematic illustration, not client data or a performance claim.

01 / Evidence map

Residues and confidence

Annotated sequence and structure views identify helices, strands, loop boundaries, missing residues, model confidence, and relevant sequence or structural references.

02 / Interpretation

What the pattern supports

The report separates observed features from predictions, notes conflicts among evidence types, and explains which regions are suitable for downstream analysis.

03 / Decision

What to do next

For an uncertain loop adjacent to a proposed pocket: defer a single-pose docking claim; review alternate models and available ligand evidence before choosing a validation experiment.

Typical deliverables: annotated residue and structure files, comparison figures, method and input records, an evidence and limitation summary, and a project-specific next-step recommendation. The final scope is agreed before work begins.
Evidence boundaries

What the Analysis Can—and Cannot—Establish

FindingUseful interpretationWhat it does not proveNext evidence to consider
High-confidence helix or strandLocal geometry is plausible in the modeled context.Correct interdomain orientation, complex state, or functional mechanism.PAE or complex confidence, structural comparison, functional data.
Low-confidence segmentA region needs careful review and may be flexible or conditionally structured.That the segment is always disordered or has no function.Partner context, disorder analysis, construct data, experimental characterization.
Different wild-type and variant mapsA hypothesis for a local structural difference.A measured gain or loss of stability or activity.Replicate models, sequence context, biophysical or functional assays.
Changes across MD framesA sampled structural behavior under stated simulation conditions.A complete conformational ensemble or observed cellular behavior.Sampling review, orthogonal simulation, relevant experiments.
A scoped workflow

From Structural Evidence to the Next Test

01

Define the decision

Agree on the target, region, comparison, biological question, and evidence required for a useful conclusion.

02

Qualify the inputs

Check sequence and residue numbering, model provenance, confidence, chain context, and experimental references.

03

Analyze in context

Assign secondary structure from coordinates when available; compare models, variants, confidence, conservation, and dynamic data as appropriate.

04

Recommend next steps

Document supported findings, unresolved questions, and the most informative modeling or experimental follow-up.

Why CD ComputaBio

A Structural Answer You Can Act On

Question-led scope

We start from the decision your team faces and avoid selling a standalone annotation when freely available data already answers it.

Traceable evidence

Models, assumptions, reference structures, and uncertain regions are visible in the report so a downstream scientist can review the conclusion.

Connected next steps

When the question extends beyond local structure, we define how protein modeling, MD, docking, or an appropriate experiment can resolve it.

FAQs

Frequently Asked Questions

Usually not. Public tools and structure databases can provide routine predictions or assignments. Our project work is useful when the annotations must be assessed with model quality, variants, experimental evidence, or a specific downstream decision.

Yes. We review local confidence, low-confidence regions, domain relationships, relevant experimental structures, and the intended downstream use. A high local confidence score alone does not establish the orientation of multiple domains.

Not by itself. A changed helix, strand, or loop assignment is a structural hypothesis. Sequence context, model quality, broader interactions, and a suitable stability or functional assay are needed to assess the effect.

No. It may be flexible, conditionally structured in a complex, poorly modeled, or genuinely disordered. We review the biological context before making a claim.

Yes, as part of a scoped modeling or design question. Loop and helix patterns can guide hypotheses, but affinity, aggregation, solubility, and activity require additional evidence.

RNA folding uses different constraints and outputs from protein helix and strand assignment. Send the RNA sequence and your biological question, and we will propose a separate RNA-focused scope where appropriate.

A protein sequence or structure, the region or variants of interest, and one sentence describing the decision you face are enough for an initial review. Share assay results or a reference structure if available.

A scoped report can include residue-level annotations, quality and evidence maps, comparison figures, methods, limits, and recommended next analyses or experiments. Specific deliverables are agreed before execution.

Online Inquiry

Submit your project details below, and our team will respond within 24 hours.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk